Randomized Trial of Micafungin for the Prevention of Invasive Fungal Infection in High-Risk Liver Transplant Recipients

Faouzi Saliba(Hôpital Paul-Brousse), Ya. G. Moysyuk, Jan J. De Waele(Ghent University Hospital), Manuela Lugano(Semmelweis University), Jesús Fortün(Evidence (Italy)), Cathérine Paugam‐Burtz(Hôpital Beaujon), Carlos Cervera(University of Alberta), Evaristo Varó(Astellas Pharma (United Kingdom)), Umberto Cillo(University of Padua), Irinel Popescu(Institutul Clinic Fundeni), Peter Schemmer(Heidelberg University), Lorraine Tweddle(Astellas Pharma (United Kingdom)), Bo Göran-Ericzon(Karolinska University Hospital), Daniel Eyraud, Mauro Salizzoni(Azienda Ospedaliero Universitaria San Giovanni Battista), Pierre‐François Laterre(Cliniques Universitaires Saint-Luc), Luís Tomé(Hospitais da Universidade de Coimbra), Stephen Phillips(Dalhousie University), Lionel Rostaing(Centre Hospitalier Universitaire de Grenoble), P. Michielsen(University of Antwerp), Christophe Moreno(Genfit (France)), Emilio Bouza(Hospital General Universitario Gregorio Marañón), Andrea De Gasperi(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Johan Decruyenaere(Ghent University Hospital), P. Aiden McCormick, Nigel Heaton(King's College - North Carolina), Johann Pratschke(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Tahir Shah, R.M. Langer(Krankenhaus der Elisabethinen), Julián de la Torre(Astellas Pharma (United States)), Andreas Karas(Astellas Pharma (United Kingdom)), P. Neuhaus(Charité - Universitätsmedizin Berlin), Marino Blanes, Miguel Montejo, Malcolm W. Brown(Astellas Pharma (Japan)), Andreas Pascher(Charité - Universitätsmedizin Berlin), Jorge Daniel, Olivier Cointault(Hôpital Rangueil)
Clinical Infectious Diseases
December 17, 2014
Cited by 80


Related Papers